Detalhe da pesquisa
1.
FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients.
Tumour Biol
; 42(7): 1010428320938494, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32628088
2.
Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients.
Oncotarget
; 9(51): 29538-29547, 2018 07 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30038702
3.
GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation.
Basic Clin Pharmacol Toxicol
; 121(6): 520-525, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28686330
4.
XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.
Oncotarget
; 8(10): 16190-16201, 2017 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26918827
5.
Do genetic polymorphisms modulate response rate and toxicity of Cisplatin associated with radiotherapy in laryngeal squamous cell carcinoma?: a case report.
Medicine (Baltimore)
; 94(16): e578, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25906090